Pages that link to "Q40567924"
Jump to navigation
Jump to search
The following pages link to The biology of erbB-2/neu/HER-2 and its role in cancer (Q40567924):
Displaying 50 items.
- Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members (Q21195197) (← links)
- Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase (Q22009924) (← links)
- Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells (Q22254244) (← links)
- An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer (Q24297853) (← links)
- ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner (Q24522643) (← links)
- Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors (Q24532786) (← links)
- N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration (Q24535534) (← links)
- Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 (Q24538180) (← links)
- Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks (Q24645403) (← links)
- A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor (Q24648517) (← links)
- Positive and negative regulation of endogenous genes by designed transcription factors (Q24649843) (← links)
- The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer (Q24656159) (← links)
- The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation (Q24678674) (← links)
- Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis (Q24679619) (← links)
- Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu (Q24683893) (← links)
- Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases (Q24802950) (← links)
- Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer (Q24803054) (← links)
- Changing strategies for target therapy in gastric cancer (Q26774513) (← links)
- Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review (Q26777733) (← links)
- Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease (Q26800001) (← links)
- Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways (Q26821895) (← links)
- HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies (Q26822730) (← links)
- Structural Insights into the Down-regulation of Overexpressed p185her2/neu Protein of Transformed Cells by the Antibody chA21 (Q27670462) (← links)
- The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor (Q28118420) (← links)
- Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells (Q28206850) (← links)
- Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis (Q28386225) (← links)
- Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data (Q28469088) (← links)
- Assembly of bio-nanoparticles for double controlled drug release (Q28536927) (← links)
- Distinct Tyrosine Autophosphorylation Sites Negatively and Positively Modulate Neu-Mediated Transformation (Q28577281) (← links)
- ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice (Q28590176) (← links)
- ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation (Q28594099) (← links)
- The cellular response to neuregulins is governed by complex interactions of the erbB receptor family (Q28609130) (← links)
- ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer (Q28678776) (← links)
- Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers (Q28679173) (← links)
- The ErbB signaling network: receptor heterodimerization in development and cancer (Q29617919) (← links)
- Src family kinases and HER2 interactions in human breast cancer cell growth and survival (Q30307291) (← links)
- Treatment of vestibular schwannoma cells with ErbB inhibitors (Q30458767) (← links)
- Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus. (Q30479942) (← links)
- Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer (Q30493117) (← links)
- Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library (Q30712761) (← links)
- Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction (Q30879242) (← links)
- Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes (Q33382437) (← links)
- Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis (Q33503420) (← links)
- Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival (Q33618685) (← links)
- Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells (Q33626062) (← links)
- Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha (Q33690338) (← links)
- Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways (Q33724768) (← links)
- Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer (Q33760811) (← links)
- Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface (Q33778555) (← links)
- Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion (Q33779668) (← links)